Roswell Park to open $98M cell and gene therapy manufacturing facility

Michael Wong joins Roswell Park as physician-in-chief

Michael Wong joined Roswell Park Comprehensive Cancer Center as the center’s first physician-in-chief.

December 06, 2024

Hemokine modulatory regimen shows promise for TNBC in phase I study

A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase I clinical trial for patients with triple-negative breast cancer, the most aggressive type of breast cancer. Results of the study are newly reported in The Journal for ImmunoTherapy of Cancer.

November 22, 2024

Vol.50 No.44

Clinical Roundup

Engineered HSV can trigger genetic chain reaction, rearrange HSV genes during co-infection

In preclinical work recently published in Nature Communications, Fred Hutchinson Cancer Center scientists used a genetic “chain reaction” to transform herpes simplex virus DNA during an HSV infection.

November 15, 2024

Vol.50 No.43

In Brief

Roswell Park receives $7.7M for biobank

Rep. Tim Kennedy (NY-D) announced $7,731,872 in new federal funding for Roswell Park Comprehensive Cancer Center to renovate its newly integrated biobank, the Roswell Park Biorepository, made possible through the Office of the Director of NIH’s Research Facilities Construction Grants.

October 11, 2024

Vol.50 No.38

In Brief

Thomas Schwaab named medical director of ChristianaCare’s Helen F. Graham Cancer Center & Research Institute

Thomas Schwaab was named Bank of America Endowed Medical Director of ChristianaCare’s Helen F. Graham Cancer Center & Research institute.

September 13, 2024

Vol.50 No.34

In Brief

MD Anderson and industry partners to conduct T cell studies on the International Space Station

The University of Texas MD Anderson Cancer Center and collaborators are initiating a research project that will send T cells to the International Space Station to study the effects of prolonged microgravity on cell differentiation, activation, memory, and exhaustion.

August 02, 2024

Vol.50 No.31

Roswell Park to open $98M cell and gene therapy manufacturing facility

YOU MAY BE INTERESTED IN

Michael Wong joins Roswell Park as physician-in-chief

Hemokine modulatory regimen shows promise for TNBC in phase I study

Engineered HSV can trigger genetic chain reaction, rearrange HSV genes during co-infection

Roswell Park receives $7.7M for biobank

Thomas Schwaab named medical director of ChristianaCare’s Helen F. Graham Cancer Center & Research Institute

MD Anderson and industry partners to conduct T cell studies on the International Space Station

Renew today!

Subscriber content

Never miss an issue!

Login